tirzepatide health canada approval approves Mounjaro (tirzepatide) for children 10 years and… Zepbound approved in Canada for

Scientists from the WHO recently wrote: "The approval of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the treatment of obesity creates potential for a transformation of the whole health system that could halt and reverse the global obesity pandemic through prevention and effective integrated management." Growing crisis South Africa is grappling with dual diabetes and obesity epidemics, on top of the HIV and TB epidemics, but is not responding effectively, resulting in high obesity and diabetes-related deaths

Incretin-based therapy: A powerful and promising weapon in the treatment of type 2 diabetes mellitus

Week 2: Draw 0.50 mL for 2.5 mg

Understanding proper dosage calculations ensures accuracy at every dose level